Carson Wealth (CWM LLC)’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$694K Sell
4,244
-103
-2% -$15.8K ﹤0.01% 1790
2025
Q4
$757K Buy
4,347
+1,892
+77% +$345K ﹤0.01% 1661
2025
Q3
$354K Buy
2,455
+724
+42% +$88.7K ﹤0.01% 1998
2025
Q2
$174K Sell
1,731
-321
-16% -$24.5K ﹤0.01% 2294
2025
Q1
$157K Buy
2,052
+404
+25% +$30.9K ﹤0.01% 2081
2024
Q4
$114K Buy
1,648
+198
+14% +$14.3K ﹤0.01% 2198
2024
Q3
$106K Sell
1,450
-120
-8% -$8.86K ﹤0.01% 2164
2024
Q2
$105K Buy
1,570
+155
+11% +$6.01K ﹤0.01% 1949
2024
Q1
$38K Buy
1,415
+14
+1% +$392 ﹤0.01% 2478
2023
Q4
$43K Sell
1,401
-38
-3% -$985 ﹤0.01% 2270
2023
Q3
$36K Buy
1,439
+44
+3% +$1.01K ﹤0.01% 2284
2023
Q2
$29K Sell
1,395
-214
-13% -$4.06K ﹤0.01% 2393
2023
Q1
$27K Buy
1,609
+65
+4% +$1.26K ﹤0.01% 2293
2022
Q4
$31K Buy
1,544
+1,337
+646% +$25.8K ﹤0.01% 2059
2022
Q3
$4K Buy
207
+51
+33% +$1.22K ﹤0.01% 3179
2022
Q2
$3K Buy
156
+24
+18% +$503 ﹤0.01% 3203
2022
Q1
$3K Buy
132
+118
+843% +$2.74K ﹤0.01% 3040
2021
Q4
$0 Buy
+14
New +$400 ﹤0.01% 3561

Other funds holding INSM

Carson Wealth (CWM LLC)'s INSM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Insmed (INSM) stake by 2.4% in Q1 2026, selling an estimated $15.8K and leaving 4,244 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Carson Wealth (CWM LLC) first reported a position in INSM in Q4 2021 and has held it in 18 quarters since. The position peaked at $757K in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 4,244 shares of Insmed worth $694K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 103 Insmed shares in Q1 2026, an estimated $15.8K.
  • Insmed made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1790 holding.
  • Carson Wealth (CWM LLC) first reported a position in Insmed in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Insmed position peaked at $757K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.